Effects of Colesevelam Hydrochloride (WelChol) on Biomarkers of Inflammation in Patients With Mild Hypercholesterolemia

This publication has 13 references indexed in Scilit:

• Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia
  Current Medical Research and Opinion, 2005
• Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
  Circulation, 2003
• Effectiveness of Colesevelam Hydrochloride in Decreasing LDL Cholesterol in Patients With Primary Hypercholesterolemia: A 24-Week Randomized Controlled Trial
  Mayo Clinic Proceedings, 2001
• Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively
  Atherosclerosis, 2001
• Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
  New England Journal of Medicine, 2001
• Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia
  Clinical Cardiology, 2001
• Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
  Circulation, 2001
• Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications
  Circulation, 2000
• C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
  New England Journal of Medicine, 2000
• Colesevelam Hydrochloride (Cholestagel)
  Archives of internal medicine (1960), 1999